Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000573411 | SCV000665440 | likely benign | Hereditary cancer-predisposing syndrome | 2015-08-19 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000573411 | SCV000687308 | likely benign | Hereditary cancer-predisposing syndrome | 2017-10-26 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000628254 | SCV000749149 | likely benign | Ataxia-telangiectasia syndrome | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001595022 | SCV001829468 | benign | not provided | 2015-04-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001595022 | SCV004184187 | likely benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | ATM: BP4, BP7 |
Myriad Genetics, |
RCV004592666 | SCV005084350 | benign | Familial cancer of breast | 2024-04-29 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Prevention |
RCV004553265 | SCV004779323 | likely benign | ATM-related disorder | 2020-04-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |